申请人:Novo Nordisk A/S
公开号:US05589467A1
公开(公告)日:1996-12-31
A compound of formula (I), or a pharmaceutically acceptable salt thereof: ##STR1## wherein X is halogen, amino, perhalomethyl, cyano, C.sub.1-6 -alkoxy, C.sub.1-6 -alkylthio or C.sub.1-6 -alkylamino; A is methyl, halomethyl, cyanomethyl, aminomethyl, vinyl, methylthiomethyl or methoxymethyl; R.sup.1 is selected from optionally substituted N-bonded heterocyclics. The compounds have been found useful for treating central nervous system ailments.
公式(I)的化合物,或其药用盐:##STR1##其中X是卤素,氨基,全氟甲基,氰基,C.sub.1-6-烷氧基,C.sub.1-6-烷硫基或C.sub.1-6-烷氨基;A是甲基,卤甲基,氰基甲基,氨基甲基,乙烯基,硫甲基或甲氧基甲基;R.sup.1来自可选择替代的N-键合杂环。已发现这些化合物对治疗中枢神经系统疾病有用。